Immunohistochemical results showed positivity for CD3, CD4, CD5, CD7, and CD8, indicating cutaneous T-cell lymphoma (CTCL) Sezary Syndrome (Figure 4). The gene discussed is CD5; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.